ORXCF(ORXCF)
ORXCF
No analyst ratings available
No analyst price targets available for ORXCF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $3.78T | $3.53T | $3.70T | $3.88T | $4.09T |
| Low | $3.73T | $3.41T | $3.61T | $3.79T | $3.99T |
| High | $3.82T | $3.62T | $3.77T | $3.95T | $4.16T |
| EBITDA Avg | $1.36T | $1.27T | $1.33T | $1.39T | $1.47T |
| Low | $1.34T | $1.22T | $1.30T | $1.36T | $1.43T |
| High | $1.37T | $1.30T | $1.35T | $1.42T | $1.49T |
| EBIT Avg | $777.35B | $726.62B | $761.72B | $798.62B | $840.34B |
| Low | $767.16B | $700.64B | $742.93B | $778.92B | $819.62B |
| High | $785.43B | $744.01B | $774.90B | $812.44B | $854.88B |
| Net Income Avg | $4.35B | $3.40B | $3.69B | $4.07B | $4.42B |
| Low | $4.21B | $3.29B | $3.57B | $3.94B | $4.28B |
| High | $4.44B | $3.48B | $3.77B | $4.16B | $4.52B |
| EPS Avg | $616.15 | $482.00 | $523.02 | $576.85 | $626.54 |
| Low | $596.40 | $466.55 | $506.25 | $558.35 | $606.45 |
| High | $630.01 | $492.84 | $534.78 | $589.82 | $640.63 |
| Analysts (Rev / EPS) | 4 / 1 | 6 / 1 | 5 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.40T | $972.60B | $677.32B | $821.87B | $840.11B | $858.35B | $876.58B | $955.22B |
| Low | $1.40T | $972.60B | $677.32B | $821.87B | $840.11B | $858.35B | $876.58B | $955.22B |
| High | $1.40T | $972.60B | $677.32B | $821.87B | $840.11B | $858.35B | $876.58B | $955.22B |
| EBITDA Avg | $501.37B | $348.86B | $242.95B | $294.80B | $301.34B | $307.88B | $314.42B | $342.63B |
| Low | $501.37B | $348.86B | $242.95B | $294.80B | $301.34B | $307.88B | $314.42B | $342.63B |
| High | $501.37B | $348.86B | $242.95B | $294.80B | $301.34B | $307.88B | $314.42B | $342.63B |
| EBIT Avg | $287.46B | $200.02B | $139.30B | $169.03B | $172.78B | $176.53B | $180.28B | $196.45B |
| Low | $287.46B | $200.02B | $139.30B | $169.03B | $172.78B | $176.53B | $180.28B | $196.45B |
| High | $287.46B | $200.02B | $139.30B | $169.03B | $172.78B | $176.53B | $180.28B | $196.45B |
| Net Income Avg | $265.19B | $160.49B | $73.38B | $109.42B | $111.85B | $114.28B | $117.29B | $127.12B |
| Low | $265.19B | $160.49B | $73.38B | $109.42B | $111.85B | $114.28B | $117.29B | $127.12B |
| High | $265.19B | $160.49B | $73.38B | $109.42B | $111.85B | $114.28B | $117.29B | $127.12B |
| EPS Avg | $244.10 | $147.72 | $67.55 | $100.72 | $102.96 | $105.19 | $107.96 | $117.01 |
| Low | $244.10 | $147.72 | $67.55 | $100.72 | $102.96 | $105.19 | $107.96 | $117.01 |
| High | $244.10 | $147.72 | $67.55 | $100.72 | $102.96 | $105.19 | $107.96 | $117.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |